SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-19-002765
Filing Date
2019-02-08
Accepted
2019-02-08 15:03:07
Documents
2
Group Members
CITIGROUP FINANCIAL PRODUCTS INC.CITIGROUP GLOBAL MARKETS HOLDINGS INC.CITIGROUP GLOBAL MARKETS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A formsc13ga.htm SC 13G/A 148608
2 EXHIBIT 1 ex99_1.htm EX-99.1 11447
  Complete submission text file 0001140361-19-002765.txt   162249
Mailing Address 388 GREENWICH STREET NEW YORK NY 10013
Business Address 388 GREENWICH STREET NEW YORK NY 10013 2125591000
CITIGROUP INC (Filed by) CIK: 0000831001 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
Assistant Director 7

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 19579458
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1